Associations of fatty liver disease and other factors affecting serum SHBG concentrations: A population based study on 1657 subjects

Hormone and Metabolic Research

Volumn 46, Issue 4, 2014, Pages 287-293

  Flechtner Mors, M ^a   Schick, A ^b   Oeztuerk, S ^b   Haenle, M M ^b   Wilhelm, M ^c   Koenig, W ^b   Imhof, A ^b   Boehm, B O ^b   Graeter, T ^b   Mason, R A ^d   Kratzer, W ^b   Akinli, A S ^b  

^a Institute of Epidemiology Ulm   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c ULM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

cross sectional study; metabolic syndrome; NAFLD; ultrasonography

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CERULOPLASMIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; PROINSULIN; SEX HORMONE BINDING GLOBULIN; TRANSFERRIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GERMANY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST HIP RATIO; ADOLESCENT; AGED; BLOOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREMENOPAUSE; SEX HORMONE-BINDING GLOBULIN; YOUNG ADULT;

EID: 84899472055     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1354369     Document Type: Article

References (31)

1. Caldwell J. D., Jirikowski G. F. Sex hormone binding globulin and aging. Horm Metab Res: 2009; 41 173 182
2. Pugeat M., Nader N., Hogeveen K. Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome. Mol Cell Endocrinol: 2010; 316 53 59
3. Tchernof A., Despres J. P. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res: 2000; 32 526 536 (Pubitemid 32176082)
4. Plymate S. R., Matej L. A., Jones R. E., Friedl K. E. Inhibition of sex hormone-binding globulin production in the human hepatoma (hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab: 1988; 67 460 464
5. Selva D. M., Hogeveen K. N., Innis S. M., Hammond G. L. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest: 2007; 117 3979 3987 (Pubitemid 350224107)
6. Bellentani S., Scaglioni F., Marino M. Epidemiology of non-alcoholic fatty liver disease. Dig Dis: 2010; 28 155 161
7. Angulo P., Lindor K. D. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol: 2002; 17 186 190
8. Liu Q., Bengmark S., Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis: 2010; 9 42
9. Kogiso T., Moriyoshi Y., Nagahara H. Clinical significance of fatty liver associated with metabolic syndrome. Hepatol Res: 2007; 37 711 721 (Pubitemid 47054777)
10. Laaksonen D. E., Niskanen L., Punnonen K., Nyyssönen K., Tuomainen T. P., Valkonen V. P., Salonen R., Salonen J. T. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care: 2004; 27 1036 1041 (Pubitemid 38579762)
11. Rodriguez A., Muller D. C., Metter E. J., Maggio M., Harman S. M., Blackman M. R., Andres R. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab: 2007; 92 3568 3572 (Pubitemid 47435336)
12. Stefan N., Schick F., Haring H. U. Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med: 2009; 361 2675 2676 author reply 2677-2678
13. Peter A., Kantartzis K., Machann J., Schick F., Staiger H., Machicao F., Schleicher E., Fritsche A., Häring H. U., Stefan N. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes: 2010; 59 3167 3173
14. Carlstrom K., Eriksson S., Rannevik G. Sex steroids and steroid binding proteins in female alcoholic liver disease. Acta Endocrinol (Copenh): 1986; 111 75 79 (Pubitemid 16187049)
15. Myking O., Aakvaag A., Digranes O. Androgen-oestrogen imbalance in men with chronic alcoholism and fatty liver. Alcohol Alcohol: 1987; 22 7 15 (Pubitemid 17088168)
16. Bell H., Frey H., Haug E., Raknerud N. Gonad function in men with alcoholic liver disease. Tidsskr Nor Laegeforen: 1990; 110 1361 1365
17. Kaulhausen H., Rohner H. G., Siedek M., Lafosse M., Breuer H. Binding capacity of sex hormone binding globulin and corticosteroid binding globulin in serum of male patients with liver cirrhosis (author's transl). J Clin Chem Clin Biochem: 1980; 18 137 143 (Pubitemid 10184022)
18. Physical status: The use and interpretation of anthropometry Report of a WHO expert committee. World Health Organization Technical Report Series: 1995; 854 1 452
19. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem: 1972; 18 499 502
20. Saverymuttu S. H., Joseph A. E., Maxwell J. D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med Journal (Clin Res Ed): 1986; 292 13 15 (Pubitemid 16175875)
21. Hamaguchi M., Kojima T., Itoh Y., Harano Y., Fujii K., Nakajima T., Kato T., Takeda N., Okuda J., Ida K., Kawahito Y., Yoshikawa T., Okanoue T. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol: 2007; 102 2708 2715 (Pubitemid 350179336)
22. Charatcharoenwitthaya P., Lindor K. D. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis: 2007; 11 37 54 viii (Pubitemid 46829975)
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA: 2001; 285 2486 2497
24. Graffigna M. N., Belli S. H., de Larranaga G., Fainboim H., Estepo C., Peres S., García N., Levalle O. Insulin-like growth factor-binding protein-1: A new biochemical marker of nonalcoholic fatty liver disease? Acta Gastroenterol Latinoam: 2009; 39 30 37
25. Kalme T., Seppala M., Qiao Q., Koistinen R., Nissinen A., Harrela M., Loukovaara M., Leinonen P., Tuomilehto J. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. J Clin Endocrinol Metab: 2005; 90 1550 1556 (Pubitemid 40464017)
26. Laaksonen D. E., Niskanen L., Punnonen K., Nyyssönen K., Tuomainen T. P., Salonen R., Rauramaa R., Salonen J. T. Sex hormones, inflammation and the metabolic syndrome: A population-based study. Eur J Endocrinol: 2003; 149 601 608 (Pubitemid 38054707)
27. American Diabetes Association Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (Committee Report). Diabetes Care: 1997; 20 1183 1197
28. Bonnet F., Cephise F. L., Gautier A., Dubois S., Massart C., Camara A., Larifla L., Balkau B., Ducluzeau P. H. Role of sex steroids, intra-hepatic fat and liver enzymes in the association between SHBG and metabolic features. Clin Endocrinol (Oxf): 2012; 10.1111/cen 12089 [Epub ahead of print]
29. Fishbein M., Castro F., Cheruku S., Jain S., Webb B., Gleason T., Stevens W. R. Hepatic MRI for fat quantitation: Its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol: 2005; 39 619 625 (Pubitemid 41061269)
30. Qayyum A., Chen D. M., Breiman R. S., Westphalen A. C., Yeh B. M., Jones K. D., Lu Y., Coakley F. V., Callen P. W. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: Which modality is best? Clin Imaging: 2009; 33 110 115
31. Grant L. M., Lisker-Melman M. Nonalcoholic fatty liver disease. Ann Hepatol: 2004; 3 93 99